Blood · 2016 · 386 citations · 36 references
MedicineHematologyOncologyHematologic OncologyMolecular OncologyNeoplasiaCancer CytogeneticsCancer RiskHematologic MalignanciesLymphoid NeoplasmsLymphoid TumorsMalignant NeoplasmsAcute LeukemiasAcute Lymphoblastic Leukemia BiologyLeukemia ClassificationLeukemia CytogeneticsRelapsed Acute Lymphoblastic Leukemia
Key Points Approximately 20% to 25% of adults with B-ALL have Ph-like ALL with increased frequency of Ph-like ALL in adults with Hispanic ethnicity. Adult patients with CRLF2+ ALL have poor long-term outcomes; novel strategies are needed to improve the outcomes.
36
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
Charles G. Mullighan, Xiaoping Su, Jinghui Zhang et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text
Life Sciences, Genetics, Hematology +15
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Kathryn G. Roberts, Yongjin Li, Debbie Payne-Turner et al. · New England Journal of Medicine · 2014 · 1.4K citations · Full text
Life Sciences, Genetics, Oncology +17
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan, Christopher B. Miller, Ina Radtke et al. · Nature · 2008 · 1.1K citations
Anthony H. Goldstone, Susan Richards, Hillard M. Lazarus et al. · Blood · 2007 · 782 citations · Full text
Medicine, Hematology, Oncology +16